Ana María
Gonzalez-Pinto Arrillaga
University of Cambridge
Cambridge, Reino UnidoPublicacións en colaboración con investigadores/as de University of Cambridge (9)
2024
-
Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders
Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389
2022
-
The effect of early life events on glucose levels in first-episode psychosis
Frontiers in Endocrinology, Vol. 13
2020
-
Assessing irritability in patients with stroke: psychometric properties of the Irritability Questionnaire
Brain Injury, Vol. 34, Núm. 1, pp. 115-121
-
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study
Schizophrenia Research, Vol. 218, pp. 292-294
2017
-
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics
Frontiers in Neuroendocrinology, Vol. 45, pp. 25-34
2016
-
Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders
European Psychiatry, Vol. 38, pp. 61-69
-
Peripheral inflammatory parameters in late-life depression: A systematic review
International Journal of Molecular Sciences, Vol. 17, Núm. 12
2010
-
Morbidity in 303 first-episode bipolar I disorder patients
Bipolar Disorders, Vol. 12, Núm. 3, pp. 264-270
2007
-
Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study
Actas Espanolas de Psiquiatria, Vol. 35, Núm. 5, pp. 315-322